Canada markets open in 9 hours 13 minutes

Vivos Therapeutics, Inc. (VVOS)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
2.2400-0.0200 (-0.88%)
At close: 04:00PM EDT
2.2100 -0.03 (-1.34%)
After hours: 07:58PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 7.23M
Enterprise Value 6.50M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)0.26
Price/Book (mrq)12.42
Enterprise Value/Revenue 0.49
Enterprise Value/EBITDA -0.21

Trading Information

Stock Price History

Beta (5Y Monthly) 7.99
52-Week Change 3-73.95%
S&P500 52-Week Change 328.04%
52 Week High 348.7900
52 Week Low 31.9600
50-Day Moving Average 33.1706
200-Day Moving Average 36.3179

Share Statistics

Avg Vol (3 month) 3177.21k
Avg Vol (10 day) 398.32k
Shares Outstanding 53.23M
Implied Shares Outstanding 63.23M
Float 82M
% Held by Insiders 16.77%
% Held by Institutions 112.97%
Shares Short (Apr 30, 2024) 462.78k
Short Ratio (Apr 30, 2024) 40.18
Short % of Float (Apr 30, 2024) 43.05%
Short % of Shares Outstanding (Apr 30, 2024) 42.11%
Shares Short (prior month Mar 28, 2024) 418.69k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:25
Last Split Date 3Oct 27, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin -98.42%
Operating Margin (ttm)-127.25%

Management Effectiveness

Return on Assets (ttm)-88.43%
Return on Equity (ttm)-521.22%

Income Statement

Revenue (ttm)13.8M
Revenue Per Share (ttm)11.32
Quarterly Revenue Growth (yoy)-17.80%
Gross Profit (ttm)N/A
EBITDA -16.68M
Net Income Avi to Common (ttm)-13.58M
Diluted EPS (ttm)-11.1400
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.64M
Total Cash Per Share (mrq)0.6
Total Debt (mrq)2M
Total Debt/Equity (mrq)485.40%
Current Ratio (mrq)0.34
Book Value Per Share (mrq)0.22

Cash Flow Statement

Operating Cash Flow (ttm)-11.95M
Levered Free Cash Flow (ttm)-7.69M